DEC-205/NY-ESO-1 Fusion Protein CDX-1401, Poly ICLC, Decitabine, and Nivolumab in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia
Roswell Park Cancer Institute
Roswell Park Cancer Institute
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Boston Children's Hospital
Thomas Jefferson University
Dartmouth-Hitchcock Medical Center
Masonic Cancer Center, University of Minnesota
Duke University
Fadoi Foundation, Italy
Thomas Jefferson University
Fred Hutchinson Cancer Center
AstraZeneca
Ottawa Hospital Research Institute
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
AstraZeneca
Virginia Commonwealth University
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Alliance Foundation Trials, LLC.
Sobi, Inc.
M.D. Anderson Cancer Center
Celgene
OHSU Knight Cancer Institute
Alexion Pharmaceuticals, Inc.
Pfizer
M.D. Anderson Cancer Center
Hoffmann-La Roche
Novartis
Hoffmann-La Roche
Merck Sharp & Dohme LLC
Dana-Farber Cancer Institute
SWOG Cancer Research Network
University of Alabama at Birmingham
National Cancer Institute (NCI)
Kyntra Bio
King Hussein Cancer Center
Celgene
Roswell Park Cancer Institute
Insel Gruppe AG, University Hospital Bern
Hoffmann-La Roche
Hoffmann-La Roche
Masonic Cancer Center, University of Minnesota
Emmaus Medical, Inc.
Academic and Community Cancer Research United
University of Colorado, Denver
M.D. Anderson Cancer Center
Theravia
Fred Hutchinson Cancer Center
Reprixys Pharmaceutical Corporation
Dana-Farber Cancer Institute